Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/28984
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-10-06T06:23:29Z | - |
dc.date.available | 2022-10-06T06:23:29Z | - |
dc.date.issued | 2007-01 | - |
dc.identifier.citation | Aydoğan, K. ve Karlı, N. (2007). "Effects of oral isotretinoin therapy on peripheral nerve functions: a preliminary study". Clinical and Experimental Dermatology, 32(1), 81-84. | en_US |
dc.identifier.issn | 1365-2230 | - |
dc.identifier.issn | 0307-6938 | - |
dc.identifier.uri | https://doi.org/10.1111/j.1365-2230.2006.02268.x | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2230.2006.02268.x | - |
dc.identifier.uri | http://hdl.handle.net/11452/28984 | - |
dc.description.abstract | Accumulating evidence over the past decade indicates that synthetic retinoids may be capable of affecting both growth and differentiation of nervous tissue. Our aim was to substantiate possible side-effects of oral isotretinoin therapy on peripheral nerve functions, both neurologically and neurophysiologically. We performed neurological examination and electroneuromyographic studies on 18 patients with various skin diseases before, at the third month, and at the end of isotretinoin treatment. Abnormal neurophysiological findings in this study point towards a typical distal, length-dependent and predominantly sensory polyneuropathy. Clinicians should be aware of possible neurological sensorial symptoms during isotretinoin therapy. In our opinion, electroneuromyographic investigation should be performed on all patients reporting symptoms (e.g. paresthesia, numbness, sensory loss) before and during oral isotretinoin treatment. The precise clinical significance of the isotretinoin-induced neurophysiological alterations reported here remains to be determined in further studies. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Dermatology | en_US |
dc.subject | Neuropathy | en_US |
dc.subject | Etretinate | en_US |
dc.subject.mesh | Dermatologic agents | en_US |
dc.subject.mesh | Administration, oral | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Isotretinoin | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Neural conduction | en_US |
dc.subject.mesh | Neurologic examination | en_US |
dc.subject.mesh | Peripheral nerves | en_US |
dc.subject.mesh | Skin diseases | en_US |
dc.title | Effects of oral isotretinoin therapy on peripheral nerve functions: A preliminary study | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000242958100020 | tr_TR |
dc.identifier.scopus | 2-s2.0-33845782044 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabiilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0002-0193-1128 | tr_TR |
dc.identifier.startpage | 81 | tr_TR |
dc.identifier.endpage | 84 | tr_TR |
dc.identifier.volume | 21 | tr_TR |
dc.identifier.issue | 1 | tr_TR |
dc.relation.journal | Clinical and Experimental Dermatology | en_US |
dc.contributor.buuauthor | Aydoğan, Kenan | - |
dc.contributor.buuauthor | Karlı, Nejdet | - |
dc.contributor.researcherid | AAH-6216-2021 | tr_TR |
dc.identifier.pubmed | 17032316 | tr_TR |
dc.subject.wos | Dermatology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q2 | en_US |
dc.contributor.scopusid | 9739755800 | tr_TR |
dc.contributor.scopusid | 6506587942 | tr_TR |
dc.subject.scopus | Isotretinoin; Acne Vulgaris; Retinoids | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Isotretinoin | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Drug megadose | en_US |
dc.subject.emtree | Drug tolerance | en_US |
dc.subject.emtree | Electromyography | en_US |
dc.subject.emtree | Electrophysiology | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Laboratory test | en_US |
dc.subject.emtree | Maintenance therapy | en_US |
dc.subject.emtree | Median nerve | en_US |
dc.subject.emtree | Sensory system parameters | en_US |
dc.subject.emtree | Motor nerve conduction | en_US |
dc.subject.emtree | Sensory nerve conduction | en_US |
dc.subject.emtree | Muscle action potential | en_US |
dc.subject.emtree | Neurophysiology | en_US |
dc.subject.emtree | Sensory dysfunction | en_US |
dc.subject.emtree | Nerve function | en_US |
dc.subject.emtree | Neurologic examination | en_US |
dc.subject.emtree | Neurology | en_US |
dc.subject.emtree | Paresthesia | en_US |
dc.subject.emtree | Peripheral nerve | en_US |
dc.subject.emtree | Outcome assessment | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Side effect | en_US |
dc.subject.emtree | Skin disease | en_US |
dc.subject.emtree | Symptom | en_US |
dc.subject.emtree | Ulnar nerve | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License